Evotec expands drug discovery platform with acquisition

Monday 19 July 2010

Evotec AG is expanding its drug discovery platform with the acquisition of the privately-owned German biotechnology company, DeveloGen, which has projects underway to treat both Type 1 and Type 2 diabetes.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Germany